Launch of Myeloma BioBank
The Exciting Launch of Myeloma BioBank: James R. Berenson, MD, Multiple Myeloma, specialist announced in an interview…
read moreTargeted Oncology
Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly…
read moreAmerican Society of Hematology
Blood Journal: A Phase 1 Trial: Evaluating…Methylprednisolone: RE: ASH 2023 San Diego, CA December 9-11…
read moreMedPage Today
James R. Berenson, MD: Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience…
read moreHemOnc Today
Multiple Myeloma regimens significantly less effective in real-world treatment settings In this study, researchers looked…
read moreHealio Hematology & Oncology News
Interviewed Dr. Berenson on his perspective on Abstract 1 & Abstract 2. Questions: Reaction to…
read moreHealthTree Foundation
Has built many patient programs and over 8 integrated software platforms to help blood cancer…
read moreVJHemOnc
VJHemOnc: (The Video Journal of Hematological Oncology) is an open-access video journal dedicated to providing…
read moreDinner with the Docs – James R. Berenson, MD – Southern California
First-Line Treatment Options & Side Effects – Video Advances in Treating Relapsed Multiple Myeloma – Video…
read moreEat This, Not That! Article
Eat This, Not That! Article
read more